Repurposing FDA Approved Drugs as JNK3 Inhibitor for Prevention of Neuroinflammation Induced by MCAO in Rats
Zikra Zulfiqar,1 Fawad Ali Shah,1 Shagufta Shafique,2 Abdullah Alattar,3 Tahir Ali,4 Arooj Mohsin Alvi,1 Sajid Rashid,2 Shupeng Li5 1Department of Pharmacology, Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan; 2National Center for Bioinformatics, Qua...
Guardado en:
Autores principales: | Zulfiqar Z, Shah FA, Shafique S, Alattar A, Ali T, Alvi AM, Rashid S, Li S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3993ac6521104e28ac67bcf2e6a69281 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Role of the phosphatase PP4 in the activation of JNK-1 in prostate carcinoma cell lines PC-3 and LNCaP resulting in increased AP-1 and EGR-1 activity
por: INOSTROZA,JUAN, et al.
Publicado: (2005) -
EFFECT OF JNK MAPK ON THE REPAIR OF DAMAGED SKELETAL MUSCLE
por: I. A. Shurygina, et al.
Publicado: (2018) -
Inflammation and JNK's Role in Niacin-GPR109A Diminished Flushed Effect in Microglial and Neuronal Cells With Relevance to Schizophrenia
por: Sabrina H. Ansarey
Publicado: (2021) -
INVOLVEMENT OF JNK MAPK CASCADES IN THE FORMATION OF ADHESIONS IN THE ABDOMINAL CAVITY
por: I. A. Shurygina, et al.
Publicado: (2018) -
LAGE3 promoted cell proliferation, migration, and invasion and inhibited cell apoptosis of hepatocellular carcinoma by facilitating the JNK and ERK signaling pathway
por: Ying Xing, et al.
Publicado: (2021)